Khalida Wani

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity”.

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell(2022)10.1016/j.ccell.2022.04.004

N/A

4.7DataRank · unranked

350 citations

Daniel H. Johnson, Noha Abdel‐Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher +32 more

Multi-modal molecular programs regulate melanoma cell state

Nature Communications(2022)10.1038/s41467-022-31510-1

N/A

0.812DataRank · unranked

26 citations

Junna Oba, Chang‐Jiun Wu, Haifeng Zhu, Tatiana V. Karpinets, Caitlin Creasy +31 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

UNC Libraries(2020)10.17615/cy5h-9p96

N/A

0DataRank · unranked

0 citations

Sama Ahsan, Erwin G. Van Meir, Miguel A. Guzmán, Amulya A. Nageswara Rao, Uri Tabori +95 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0DataRank · unranked

424 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

Cell Reports(2021)10.1016/j.celrep.2021.109410

N/A

0DataRank · unranked

31 citations

Ming Tang, Mayinuer Maitituoheti, Ayush T. Raman, Archit K. Ghosh, Jonathan E. Schulz +21 more

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Cancers(2021)10.3390/cancers13215301

N/A

0DataRank · unranked

12 citations

Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han +18 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

The Journal of Experimental Medicine(2022)10.1084/jem.20221333

N/A

0DataRank · unranked

64 citations

Yusra B. Medik, Bhakti Patel, Daniel Zamler, Sijie Chen, Thomas Chapman +39 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

(2022)10.52519/00101

N/A

0DataRank · unranked

3 citations

Yusra B. Medik, Bhakti K. Patel, Daniel B. Zamler, Sijie Chen, T. Chapman +39 more

Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells

Nature(2023)10.1038/s41586-023-06342-8

N/A

0DataRank · unranked

182 citations

Gianna T. Busch, Maalavika Pillai, Jingxin Li, Ryan H. Boe, Emanuelle I. Grody +30 more

Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma

Human Genetics and Genomics Advances(2023)10.1016/j.xhgg.2023.100224

N/A

0DataRank · unranked

7 citations

Chia-Chin Wu, Michael S. Nakazawa, Davis R. Ingram, Joseph R. Daniele, Rossana Lazcano +14 more

Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.01.034

N/A

0DataRank · unranked

4 citations

Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani +12 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis

The Journal of Experimental Medicine(2024)10.1084/jem.20230420

N/A

0DataRank · unranked

21 citations

William A. Molina Arocho, Tsun Ki Jerrick To, Samir Devalaraja, Irene S. Molina, Jason Shoush +26 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0DataRank · unranked

13 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more

Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0362

N/A

0DataRank · unranked

7 citations

Brenda Melendez, Qian Zhang, Richard K. Yang, Bryan Fellman, Barrett C. Lawson +11 more

DNA mismatch repair deficiency as a biomarker in sarcoma

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100091

N/A

0DataRank · unranked

3 citations

Christopher D Quintana-Perez, Sintawat Wangsiricharoen, Davis R. Ingram, Khalida Wani, Alexander J. Lazar +4 more

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0761

N/A

0DataRank · unranked

3 citations

Ian M. Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson +16 more

Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11511

N/A

0DataRank · unranked

3 citations

Rossana Lazcano Segura, Ahsan Farooqi, Davis R. Ingram, Khalida Wani, Yiming Cai +13 more

Microbial signals in primary and metastatic brain tumors

Nature Medicine(2025)10.1038/s41591-025-03957-4

N/A

0DataRank · unranked

17 citations

Ashish Damania, Brenda Melendez, Bharat Singh, Fabiana J. Veguilla, Rebecca Soto +61 more

CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3324

N/A

0DataRank · unranked

7 citations

Menuka Karki, Kyle A. Blum, Jean‐Philippe Bertocchio, Rong He, Durga Nand Tripathi +17 more

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102423

N/A

0DataRank · unranked

3 citations

Nizar M. Tannir, Funda Meric-Bernstam, Jennifer King, Martin H. Voss, Jessica P Cheng +27 more

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

Frontiers in Immunology(2025)10.3389/fimmu.2025.1567736

N/A

0DataRank · unranked

4 citations

Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis R. Ingram, Khalida Wani +21 more

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature

Cancers(2025)10.3390/cancers17091441

N/A

0DataRank · unranked

4 citations

Ryan A. Denu, Davis R. Ingram, Khalida Wani, Alexander J. Lazar, Douglas J. Harrison +5 more

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma

ESMO Open(2025)10.1016/j.esmoop.2025.105493

N/A

0DataRank · unranked

1 citations

Mohamad El Zoghbi, Rossana Lazcano, Brandon Cope, Andrew J. Bishop, Ahsan Farooqi +24 more

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples

European Urology Oncology(2025)10.1016/j.euo.2025.09.018

N/A

0DataRank · unranked

0 citations

Qi Wang, Gayatri Kumar, Mahmut Akgül, Chad J. Creighton, Priya Rao +18 more

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000960

N/A

0DataRank · unranked

61 citations

Kathryn Bollin, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Kevin B. Kim, Jason Roszik +12 more

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.23.689992

N/A

0DataRank · unranked

0 citations

Anand K. Singh, Yingda Jiang, Zheng Zhao, Davis R. Ingram, Khalida Wani +28 more

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker

Cancer Medicine(2020)10.1002/cam4.3474

N/A

0DataRank · unranked

16 citations

Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang +13 more